Autotelic Bio
Cheongju
About Autotelic Bio
Autotelic Bio is a bio technology company that researches and develops anti-cancer drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $18.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2022)
- Website: autotelic.co.kr
- Phone: +82 43 233 9373
Industries & Categories
Biotechnology, Pharmaceutical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/autotelic-bio-51555 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.